Tadoba tigers gorge on flying squirrels, mongoose but sambar remains top pick
2
Nagpur: From flying squirrels to wild mongoose, and from sloth bear to hare, tigers in Tadoba have gorged on a variety of prey, with sambar being their top pick. A study conducted by researchers from the National Centre for Biological Sciences (NCBS), Bengaluru, and officials of Tadoba Andhari Tiger Reserve (TATR) revealed that the diet of tigers in the buffer zone consists of almost 23% domestic animals.
The study examined scat samples in TATR during three different seasons. Samples were collected during the monsoon (September-October 2022), winter (January-February 2023), and summer (May-June 2023) to study the diet patterns of tigers, leopards, and dhole (wild dogs).
For tigers, sambar was the most preferred prey, followed by wild boar and chital. For leopards, wild boar was the top choice, followed by sambar.
For wild dogs, sambar and chital were equally preferred, followed by wild hare.
The study, led by principal investigators from NCBS Uma Ramakrishnan and Abhinav Tyagi, found 16 species in the tiger diet in TATR from 143 samples. The study revealed that overall, 90% of the tiger's diet comprised a wild prey. When breaking it down by areas, wild prey constituted 99% of the tiger's diet is in the core and around 77% in the buffer.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Perdagangkan CFD Emas dengan Broker Tepercaya
IC Markets
Mendaftar
Undo
There were some minor shifts in diet patterns according to seasons found in the study. In the monsoon season, grey langur and jungle fowl were uniquely identified, whereas Indian peafowl and buffalo were observed in the winter diet of tigers. During the summer months, grey jungle fowl and grey mongoose appeared as distinct dietary components. However, gaur and Indian hare were notably absent from the summer scat samples.
For leopards, researchers recorded the highest dietary diversity in winter, identifying 21 different prey species in leopard scat samples. This was followed by the monsoon season, with 14 species, while the lowest diversity was observed in summer, with just 12 species detected. In winter, the leopard's diet included species such as civets, porcupine, grey junglefowl, chicken, and buffalo—species that were not found in samples from other seasons.
The monsoon diet featured unique bird species, including Indian peafowl, buttonquail, and pond heron, in addition to other prey commonly consumed throughout the year. A marked increase in the consumption of cattle, langur, and nilgai was observed during the summer, indicating a possible seasonal shift in prey availability or preference.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
2 hours ago
- NDTV
Global First: Indian Scientists Map Cervical Cancer At Molecular Level, Open Doors To Precision Treatment
In a landmark achievement that places India firmly on the global oncology map, a team of Indian scientists and clinicians has conducted the country's first-ever integrative genomic and phosphoproteomic analysis of cervical cancer. This pioneering research, based on patient samples from Bihar, a state heavily impacted by the disease, unravels why some patients fail to respond to standard treatments and suggests more effective, personalised alternatives. Led by PhD scholars Janani Sambath and Irene A. George under the mentorship of Dr. Prashant Kumar, this study represents the world's first whole-genome and global proteomics-phosphoproteomics mapping of cervical cancer. On the clinical front, Dr. Richa Chauhan, senior oncologist at Mahavir Cancer Sansthan, Patna, monitored the application of these findings in real-world scenarios. "This research is close to my heart," says Dr. Chauhan. "As a cancer physician, I see women every day, many from rural or underserved backgrounds, with late-stage cervical cancer. Being part of a study that not only decodes resistance but also proposes actionable solutions is deeply gratifying." Revealing The Genetic Drivers Of Resistance Using advanced DNA sequencing, the researchers identified two major genetic alterations common in treatment-resistant cervical tumours: An increase in the number of copies of the EGFR gene, which accelerates cancer cell growth and spread. The loss of the STK11 gene, which normally functions as a growth brake. These findings are clinically significant as EGFR can be targeted using existing cancer drugs, potentially offering life-saving treatment options for patients unresponsive to standard therapy. Proteins That Hold The Key The proteomics arm of the study revealed that the CSNK2A1 protein acts as a "master switch" in treatment-resistant tumours, enabling survival pathways. Blocking this protein with the drug silmitasertib, in combination with low-dose cisplatin, significantly reduced cancer growth in lab experiments. In parallel, the phosphoproteomics analysis uncovered another protein-STX3-consistently present at high levels in resistant tumours. Identified as a powerful biomarker, STX3's discovery has been patented by the Government of India (Patent No. 404113) and has garnered widespread national attention. Recognition On The Global Stage Dr. Prashant Kumar presented the study at the ESMO Asia Congress 2024 in Singapore, where it earned the prestigious Best Poster Award, competing against top cancer research teams worldwide. This recognition not only validates the scientific excellence of the work but also strengthens India's position in the fight against women's cancers. "This is not just a scientific achievement, it's a social imperative," says Dr. Kumar. "We're proud that our research, powered by Indian samples and minds, is creating real translational possibilities." Why It Matters For India: Cervical Cancer Impact On Indian Women Cervical cancer is the second most common cancer among Indian women, responsible for nearly 10% of all female cancer cases. Despite HPV vaccination efforts, rural states like Bihar continue to face late-stage diagnoses, underscoring the urgent need for early detection tools and improved treatment protocols. Cervical cancer begins in the cervix-the lower part of the uterus-and is typically driven by long-term infection with high-risk human papillomavirus (HPV) types, especially HPV-16 and 18. Often slow to show symptoms, it may initially involve irregular or abnormal vaginal bleeding, making regular screening (via Pap smears or HPV tests) vital for early detection and successful treatment. Globally, it ranks as the fourth most common cancer in women, with over 600,000 new cases and nearly 342,000 deaths reported in 2020. In India, the burden is even higher: age-standardised incidence is about 14.7 per 100,000 women, with a mortality rate of 9.2 per 100,000, as another study published in BMC Cancer in 2022 suggests. Roughly 96,900 new cases are diagnosed annually, with 60,000-67,000 deaths, accounting for about one-fifth of global cervical cancer burden. The five-year survival rate in India hovers around 47%, significantly lower than figures in more developed countries. Vulnerable groups, such as women from lower socioeconomic strata, rural areas, and with limited education, are disproportionately affected. Incidence rates peak among women aged 50-59, especially in regions like Northeast India, with cities like Aizawl reporting rates as high as 24 per 100,000. Alarmingly, screening rates remain abysmally low. Data from NFHS-5 shows only about 1-2% of women have ever undergone cervical cancer screening. This wide gap in awareness and access underscores a pressing public health priority. Keeping these in mind, the team behind the new breakthrough study aims to move silmitasertib-based combination regimens into clinical trials, alongside the development of targeted clinical tests to guide treatment planning. With its blend of cutting-edge molecular science and deep compassion for patients, this research offers renewed hope to thousands of women who need it most.
Time of India
2 hours ago
- Time of India
IIT Delhi gets centre of excellence in precision and personalised healthcare
New Delhi: At IIT Delhi 's research and innovation park, a new centre of excellence in precision and personalised healthcare was inaugurated, marking a significant boost to India's medical innovation ecosystem. Experts say the centre will accelerate AI-driven health tech and biotechnology breakthroughs, fast-tracking research from IIT Delhi labs to real-world patient impact. It has already begun work on advancing healthcare innovations and is dedicated to accelerating the translation of high-impact research into market-ready solutions, addressing India's urgent and evolving medical needs. The inauguration event brought together leading voices from India's innovation and healthcare ecosystem. IIT Delhi has collaborated with Wadhwani Foundation under its Wadhwani innovation network partnership for the centre. You Can Also Check: Delhi AQI | Weather in Delhi | Bank Holidays in Delhi | Public Holidays in Delhi | Gold Rates Today in Delhi | Silver Rates Today in Delhi Phase 1 of the project will focus on five domains: personalised medicine, bio-imaging and AI diagnostics, assistive tech for the elderly and differently-abled, affordable and personalised implants and wearables, and new diagnostic solutions. By addressing these priority areas, the centre aims to accelerate the development of technologies that are not only cutting-edge but also affordable and accessible, thereby bridging the gap between advanced research and real-world applications. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Free P2,000 GCash eGift UnionBank Credit Card Apply Now Undo A key mission is to establish a collaborative ecosystem where academia, industry, and govt agencies join forces to take innovations from the lab to the marketplace more efficiently. "Ultimately, the initiative aims to improve patient outcomes, reduce the burden of disease, and position India as a global leader in healthcare innovation, while setting new benchmarks for quality, affordability, and accessibility in medical technology," said an official. Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and silver prices in your area. "Get the latest news updates on Times of India, including reviews of the movie Coolie and War 2 ."
Deccan Herald
4 hours ago
- Deccan Herald
Back from the stars: Shubhanshu Shukla to land in India after ISS mission
Group Captain Shubhanshu Shukla, the first Indian to visit the International Space Station, is back and set to meet PM Modi in Delhi before heading to Lucknow, and will be back in the capital for National Space Day on August 23.
